Thromboxane A 2 receptor +795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells -466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease

Molecular Medicine Reports

Volumn 5, Issue 2, 2012, Pages 477-482

  Kohyama, Kenya ^a,b   Hashimoto, Masayuki ^a,b   Abe, Shyuzo ^a   Kodaira, Kazumi ^a   Yukawa, Tatsuo ^c   Hozawa, Soichiro ^d   Morioka, Junichiro ^a   Inamura, Hiroaki ^a   Yano, Megumi ^a   Ota, Mayumi ^a,b   Sagara, Hironori ^b   Kurosawa, Motohiro ^a  

^a Gunma Hospital for Allergic and Respiratory Diseases   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Yukawa Clinic of Internal Medicine   (Japan)

^d Hiroshima Res and Devmt Center   (Japan)

Author keywords

Aspirin exacerbated respiratory disease; Aspirin tolerant asthma; Chemoattractant receptor molecule expressed on Th2 cells; Gene polymorphism; Thromboxane A 2 receptor

Indexed keywords

ACETYLSALICYLIC ACID; CHEMOKINE RECEPTOR; CRTH2 PROTEIN; DNA; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; FORMYLPEPTIDE RECEPTOR;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN TOLERANT ASTHMA; ASTHMA; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE TARGETING; GENETIC ASSOCIATION; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PROTEIN EXPRESSION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL; AGED; ALLELE; CHEMICALLY INDUCED DISORDER; GENE FREQUENCY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; RESPIRATORY TRACT DISEASE; STATISTICAL MODEL;

ADULT; AGED; ALLELES; ASPIRIN; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RESPIRATORY TRACT DISEASES; TH2 CELLS;

EID: 84855671932     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.680     Document Type: Article

References (29)

1. Szczeklik A, Nizankowska E and Duplaga M: Natural history of aspirin-induced asthma. AIANE Investigators. European network on aspirin-induced asthma. Eur Respir J 16: 432-436, 2000.
2. Cai Y, Bjermer L and Halstensen TS: Bronchial mast cells are the dominant LTC4S-expressing cells in aspirin-tolerant asthma. Am J Respir Cell Mol Biol 29: 683-693, 2003. (Pubitemid 38045937)
3. Sanak M, Simon HU and Szczeklik A: Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350: 1599-1600, 1997. (Pubitemid 28036609)
4. Kawagishi Y, Mita H, Taniguchi M, et al: Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol 109: 936-942, 2002. (Pubitemid 34634302)
5. Kim SH, Bae JS, Suh CH, Nahm DH, Holloway JW and Park HS: Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. Allergy 60: 760-765, 2005. (Pubitemid 40769878)
6. Kim SH, Oh JM, Kim YS, et al: Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 36: 433-439, 2006.
7. Van Sambeek R, Stevenson DD, Baldasaro M, et al: 5' Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 106: 72-76, 2000. (Pubitemid 30482855)
8. Choi JH, Park HS, Oh HB, et al: Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with haplotype of 5-lipoxygenase. Hum Genet 114: 337-344, 2004.
9. Higashi N, Mita H, Ono E, et al: Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers. J Allergy Clin Immunol 125: 1084-1091, 2010.
10. O'Byrne PM and Fuller RW: The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness. Eur Respir J 2: 782-786, 1989.
11. Taylor IK, Ward PS, O'Shaughnessy KM, et al: Thromboxane A2 biosynthesis in acute asthma and after antigen challenge. Am Rev Respir Dis 143: 119-125, 1991.
12. Matsuoka T, Hirata M, Tanaka H, et al: Prostaglandin D2 as a mediator of allergic asthma. Science 287: 2013-2017, 2000.
13. Shin HD, Park BL, Jung JH, et al: Association of thromboxane A2 receptor (TBXA2R) with atopy and asthma. J Allergy Clin Immunol 112: 454-457, 2003. (Pubitemid 36981392)
14. Kim JH, Lee SY, Kim HB, et al: TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma. Clin Exp Allergy 38: 51-59, 2007.
15. Unoki M, Furuta S, Onouchi Y, et al: Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum Genet 106: 440-446, 2000. (Pubitemid 30237512)
16. Boehringer S, Epplen JT and Krawczak M: Genetic association studies of bronchial asthma - a need for Bonferroni correction? Hum Genet 107: 197, 2000.
17. Nyholt DR: Genetic case-control association studies - correcting for multiple testing. Hum Genet 109: 564-565, 2001.
18. Huang JL, Gao PS, Mathias RA, et al: Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum Mol Genet 13: 2691-2697, 2004. (Pubitemid 39485417)
19. Maeda Y, Hizawa N, Takahashi D, Fukui Y, Konno S and Nishimura M: Genetic impact of functional single nucleotide polymorphisms in the 3'-UTR region of the chemoattractant receptor expressed on Th2 cells (CRTH2) gene on asthma and atopy in a Japanese population. Int Arch Allergy Immunol 142: 51-58, 2007. (Pubitemid 46032984)
20. Kim SH, Choi JH, Park HS, et al: Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 35: 585-590, 2005.
21. Kim SH, Kim YK, Park HW, et al: Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics 17: 295-304, 2007.
22. Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS and Park HS: Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy 65: 338-346, 2010.
23. Kondo T and Abe S: Automated gene analyses by sequence-specific thermal-elution chromatography. Chromatography 18: 122-125, 1997.
24. Kohyama K, Abe S, Kodaira K, et al: Arg16Gly β2-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol 156: 405-411, 2011.
25. Hirai H, Tanaka K, Yoshie O, et al: Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193: 255-261, 2001. (Pubitemid 32524457)
26. Akahoshi M, Obara K, Hirota T, et al: Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet 117: 16-26, 2005. (Pubitemid 40778778)
27. Samter M and Beers RF Jr: Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Int Med 68: 975-983, 1968.
28. Buhl T, Meynberg HC, Kaune KM, Hunecke P, Schon MP and Fuchs T: Long-term follow-up of patients with hypersensitivity to nonsteroidal anti-inflammatory drugs reveals shortcomings in compliance and care. J Allergy Clin Immunol 127: 284-285, 2011.
29. Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M and Nagata K: Agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J Immunol 168: 981-985, 2002. (Pubitemid 34094458)